Glavine Paul purchased $1.2M of HELP
Glavine Paul (Chief Growth Officer) purchased 100,000 shares of CYBIN INC. (HELP) at $12.47 ($1.25M total) on 2026-09-08.
How this was made
The 30-second read
Why it matters
The insider purchase adds a positive data point for investors monitoring insider activity, but the amount is modest relative to the company's market cap.
Market read
Primary relevance is to HELP shareholders; broader market impact is negligible.
What to watch
Potential upcoming clinical data or partnership announcements not disclosed in the filing.
Background
SEC Form 4 filing reports insider transactions. CYBIN Inc. is a biotech company listed on Nasdaq under the ticker HELP.
Ticker impact
Chief Growth Officer Glavine Paul bought 100,000 shares of CYBIN Inc. (HELP) for $1.247M on 2026-09-08, increasing his stake to over 4.2 million shares.
Potential modest upward pressure as the market digests the insider buy.
The transaction size is over $1M, a material insider buy for a micro‑cap, but not large enough to drive a big move.
Market effects
Limited impact on the broader biotech sector; mainly a company‑specific signal.
No significant regional effect.
Minimal global relevance.
Counterpoint
The buy could be a routine portfolio rebalancing rather than a strong endorsement.
Key entities
- OfficerGlavine Paul
Chief Growth Officer of CYBIN Inc.
- CompanyCYBIN Inc.
Biotech firm trading under HELP.